Definitive Healthcare (NASDAQ:DH) Issues FY 2025 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 0.190-0.220 for the period, compared to the consensus EPS estimate of 0.290. The company issued revenue guidance of $230.0 million-$240.0 million, compared to the consensus revenue estimate of $241.2 million. Definitive Healthcare also updated its Q1 2025 guidance to 0.020-0.020 EPS.

Analyst Upgrades and Downgrades

DH has been the subject of several research reports. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Barclays restated an “underweight” rating and issued a $4.00 price target on shares of Definitive Healthcare in a research note on Monday, January 13th. Finally, Stephens began coverage on Definitive Healthcare in a research report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $5.72.

Definitive Healthcare Stock Performance

DH traded down $0.18 during midday trading on Thursday, reaching $4.92. The company had a trading volume of 671,754 shares, compared to its average volume of 764,583. Definitive Healthcare has a 1 year low of $3.19 and a 1 year high of $10.62. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The company has a market cap of $568.37 million, a P/E ratio of -1.59, a P/E/G ratio of 4.06 and a beta of 1.45. The business has a 50-day moving average of $4.63 and a two-hundred day moving average of $4.47.

Insider Buying and Selling at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the transaction, the insider now directly owns 433,830 shares in the company, valued at $2,039,001. The trade was a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 14.84% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.